Zimmer Biomet (NYSE:ZBH) said late yesterday its prez and CEO David Dvorak has resigned from his position at the head of the company, effective immediately, to be replaced on an interim basis by senior VP and CFO Daniel Florin until a permanent successor is named. The Warsaw, Ind.-based company said it is retaining “a leading executive search […]
Neurometrix
NeuroMetrix launches 1-for-8 reverse stock split
NeuroMetrix (NSDQ:NURO) said today it will engage in a 1-for-8 reverse stock split, effective today, as it looks to satisfy the $1 minimum bid price requirement for the NASDAQ capital market. Through the split, every 8 shares of the company’s common stock will be consolidated into 1 issued and outstanding share with no change in the nominal […]
NeuroMetrix closes $7m private offering
NeuroMetrix (NSDQ:NURO) said today it closed a private placement round, bringing in a total of $7 million to support the commercialization of its Quell wearable pain relief device. The Waltham, Mass.-based company said it sold 7,000 shares of Series E convertible preferred stock at $1,000 per share, as well as warrants to purchase an aggregate of […]
NeuroMetrix raises $7m in private placement of preferred stocks, warrants
NeuroMetrix (NSDQ:NURO) said today that it entered into a definitive securities purchase agreement with an undisclosed investor for a private offering of 7,000 shares of Series E convertible preferred stock at $1,000 apiece, as well as warrants to purchase 10 million shares of common stock at an exercise price of ¢70 per share. The warrants will expire […]
NeuroMetrix raises $27m to buy back convertible shares, warrants
NeuroMetrix (NSDQ:NURO) said today that it raised $26.5 million in a public offering. The offering was priced at 70¢ per share of common stock, via a warrants exercise. The warrants have an exercise price of 70¢ per share and will expire 5 years after their issuance date. The company expects to spend nearly $19.5 million from the offering to […]
NeuroMetrix wins CE Mark for Quell wearable pain relief device
NeuroMetrix (NSDQ:NURO) said today it won CE Mark approval in the European Union for its Quell wearable pain relief device, now cleared as a class IIa medical device in the region. The Waltham, Mass.-based company said that recent studies indicate that 20-40% of the adult European population suffers from chronic pain, which costs the region approximately […]
RIP serial medtech entrepreneur Spencer | Personnel Moves November 10, 2016
Serial medtech entrepreneur Dale Spencer died last week in Scottsdale, Ariz, according to the Medical Alley Association. Spencer helped found more than a dozen medical device companies, including SciMed, eV3, EndoMetabolic Solutions, ConcepTx Medical and Anulex Technologies. He also served on the boards of Boston Scientific (NYSE:BSX), Micro Therapeutics, Northstar Neuroscience, Spine Wave, Vertis Neuroscience, Velocimed […]
NeuroMetrix launches Quell fybromyalgia pilot study
NeuroMetrix (NSDQ:NURO) said today it is launching a pilot study of its Quell wearable pain relief device for treating patients with fibromyalgia. Waltham, Mass.-based NeuroMetrix said it is partnering with the Synovation medical group to carry out the study. “We have seen both clinical data and positive reviews that suggest that Quell may be beneficial in […]
NeuroMetrix seeks CE Mark for Quell OTC pain relief device
NeuroMetrix (NSDQ:NURO) said today it is seeking CE Mark approval in the European Union for over-the-counter clearance for its Quell wearable chronic pain relief system. The company touted recent studies which indicate that 20-40% of the adult European population suffer fron chronic pain, with an annual financial cost exceeding $250 billion. “Europe is the natural market […]
NeuroMetrix closes $21.3m funding round
NeuroMetrix (NSDQ:NURO) said yesterday it closed a $21.3 million round of funding through the private placement of preferred stock and warrants to support its Quell wearable pain relief device for patients with chronic pain. The Waltham, Mass.-based company said it sold 21,300 shares of Series D convertible preferred stock at $1,000 per share and warrants to […]
NeuroMetrix jumps on $21m round as Quell pain device hits 1k retail stores
NeuroMetrix (NSDQ:NURO) shares jumped yesterday after the company announced a $21 million private placement and said its Quell pain relief device is on the shelves at 1,000 retail drug stores. The private placement of 21,300 Series C shares at $1,000 apiece went to an institutional investor dedicated to backing healthcare companies, Waltham, Mass.-based NeuroMetrix said. The […]